liu.seSearch for publications in DiVA
Planned maintenance
A system upgrade is planned for 10/12-2024, at 12:00-13:00. During this time DiVA will be unavailable.
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Detection of cerebral tauopathy in P301L mice using high-resolution large-field multifocal illumination fluorescence microscopy
Univ Zurich, Switzerland; Swiss Fed Inst Technol, Switzerland; Univ Zurich, Switzerland.
Univ Zurich, Switzerland; Swiss Fed Inst Technol, Switzerland; Univ Zurich, Switzerland; Univ Zurich, Switzerland.
Swiss Fed Inst Technol, Switzerland.
Univ Zurich, Switzerland; Swiss Fed Inst Technol, Switzerland.
Show others and affiliations
2020 (English)In: Biomedical Optics Express, E-ISSN 2156-7085, Vol. 11, no 9, p. 4989-5002Article in journal (Refereed) Published
Abstract [en]

Current intravital microscopy techniques visualize tauopathy with high-resolution, but have a small field-of-view and depth-of-focus. Herein, we report a transcranial detection of tauopathy over the entire cortex of P301L tauopathy mice using large-field multifocal illumination (LMI) fluorescence microscopy technique and luminescent conjugated oligothiophenes. In vitro assays revealed that fluorescent ligand h-FTAA is optimal for in vivo tau imaging, which was confirmed by observing elevated probe retention in the cortex of P301L mice compared to non-transgenic littermates. Immunohistochemical staining further verified the specificity of h-FTAA to detect tauopathy in P301L mice. The new imaging platform can be leveraged in pre-clinical mechanistic studies of tau spreading and clearance as well as longitudinal monitoring of tau targeting therapeutics. (C) 2020 Optical Society of America under the terms of the OSA Open Access Publishing Agreement

Place, publisher, year, edition, pages
OPTICAL SOC AMER , 2020. Vol. 11, no 9, p. 4989-5002
National Category
Radiology, Nuclear Medicine and Medical Imaging
Identifiers
URN: urn:nbn:se:liu:diva-171004DOI: 10.1364/BOE.395803ISI: 000577455500011PubMedID: 33014595OAI: oai:DiVA.org:liu-171004DiVA, id: diva2:1485116
Note

Funding Agencies|Vontobel-Stiftung; VetenskapsradetSwedish Research Council [2016-00748]; European Research CouncilEuropean Research Council (ERC) [ERC-2015CoG-682379]; H2020 Marie Sklodowska-Curie Actions [746430-MSIOAM]; Stiftung Synapsis -Alzheimer Forschung Schweiz AFS [2017 CDA-03]; ERA-NET NEURON [32NE30_173678/1]; SchweizerischerNationalfonds zur Forderung derWissenschaftlichen ForschungAustrian Science Fund (FWF) [320030_179277]

Available from: 2020-11-01 Created: 2020-11-01 Last updated: 2023-02-17

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Nilsson, Peter
By organisation
ChemistryFaculty of Science & Engineering
In the same journal
Biomedical Optics Express
Radiology, Nuclear Medicine and Medical Imaging

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 28 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf